Loading clinical trials...
Loading clinical trials...
A Phase 2, Multicenter, Single Arm, Open Label Study to Evaluate the Efficacy and Safety of AK104 in Subjects With Recurrent or Metastatic Cervical Cancer
Conditions
Interventions
AK104
Locations
25
United States
Womens Cancer Research Foundation
Newport Beach, California, United States
Sylvester Comprehensive Cancer Center
Miami, Florida, United States
BRCR Medical Center
Plantation, Florida, United States
Augusta University Medical Center
Augusta, Georgia, United States
Illinois Cancer Specialists
Arlington Heights, Illinois, United States
Maryland Oncology Hematology (Plum Orchard)
Silver Spring, Maryland, United States
Start Date
July 15, 2020
Primary Completion Date
December 22, 2022
Completion Date
January 31, 2023
Last Updated
February 28, 2025
NCT06238635
NCT07186868
NCT02164461
NCT05715840
NCT04943627
NCT01846520
Lead Sponsor
Akeso
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions